Propoxycaine
Propoxycaine is an ester-type local anesthetic structurally related to procaine that blocks voltage-gated sodium channels in peripheral nerve membranes, preventing the generation and propagation of nerve impulses. It was used primarily in dentistry as an injectable local anesthetic, often in combination with procaine, for infiltration and nerve block anesthesia.
Молекулярная масса
294,3900 g/mol
LogP
3,10
TPSA
64,80 Ų
Правило пяти Липинского
Соответствует
Механизм действия
Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.
2D Структура
Cite this structure
Embed this structure
SMILES
CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC
InChI
InChI=1S/C16H26N2O3/c1-4-10-20-15-12-13(17)7-8-14(15)16(19)21-11-9-18(5-2)6-3/h7-8,12H,4-6,9-11,17H2,1-3H3
Molecular Formula
C16H26N2O3
HBD / HBA
1 / 5
Вращаемые Связи
10
Тяжёлые Атомы
21
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Часто задаваемые вопросы
Propoxycaine is an ester-type local anesthetic structurally related to procaine that blocks voltage-gated sodium channels in peripheral nerve membranes, preventing the generation and propagation of nerve impulses. It was used primarily in dentistry as an injectable local anesthetic, often in combination with procaine, for infiltration and nerve block anesthesia.
Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.
Yes, Propoxycaine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1195. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 6843. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Медицинский отказ от ответственности
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="propoxycaine"></div>
Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/propoxycaine/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>
Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/propoxycaine/
Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/propoxycaine/)
Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="propoxycaine"></drugfyi-drug>